The revenue stands at ₹3,080.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.80 per cent from ₹2,831.00 crore. This corresponds to a year-on-year *(YoY) growth of 27.80 per cent.
Operating Profit stands at ₹1,255.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 34.37 per cent from ₹934.00 crore. This corresponds to a year-on-year *(YoY) growth of 72.15 per cent.
PBDT stands at ₹1,313.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 21.24 per cent from ₹1,083.00 crore. This corresponds to a year-on-year *(YoY) growth of 55.38 per cent.
Profit Before Tax stands at ₹1,180.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 22.53 per cent from ₹963.00 crore. This corresponds to a year-on-year *(YoY) growth of 60.98 per cent.
Net Profit stands at ₹902.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 20.11 per cent from ₹751.00 crore. This represents a 65.50 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Divi's Lab. | -1.45% | -1.17% | -5.74% | 21.14% | 38.74% | 38.42% |
| Sun Pharma.Inds. | -0.62% | -0.11% | -5.27% | -11.68% | 0.53% | 2.89% |
| Torrent Pharma. | -3.37% | -1.50% | -7.96% | -10.66% | 6.22% | 24.65% |
| Zydus Lifesci. | -0.63% | 1.33% | -6.94% | 1.79% | 21.03% | 11.24% |
| Cipla | 0.53% | 0.45% | -3.74% | -5.17% | 1.51% | -15.59% |
Chairman & Independent Directo : Ramesh B V Nimmagadda
Executive Director & MD : Murali K Divi
Executive Director : N V Ramana
Executive Director / Whole Time Director / CEO : Kiran S Divi
ED / WTD - Commercial : Nilima Prasad Divi
Executive Director / Whole Time Director : S. Devendra Rao
Independent Non Exe. Director : S Ganapaty
Independent Non Exe. Director : Sunaina Singh
Independent Non Exe. Director : Kosaraju Veerayya Chowdary
Independent Non Exe. Director : Rajendrakumar Premchand Shah
Company Sec. & Compli. Officer : Satish Choudhury